Ulrich Wahn

36.8k total citations · 3 hit papers
383 papers, 21.2k citations indexed

About

Ulrich Wahn is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulrich Wahn has authored 383 papers receiving a total of 21.2k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Physiology, 216 papers in Immunology and Allergy and 104 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulrich Wahn's work include Asthma and respiratory diseases (222 papers), Allergic Rhinitis and Sensitization (188 papers) and Food Allergy and Anaphylaxis Research (101 papers). Ulrich Wahn is often cited by papers focused on Asthma and respiratory diseases (222 papers), Allergic Rhinitis and Sensitization (188 papers) and Food Allergy and Anaphylaxis Research (101 papers). Ulrich Wahn collaborates with scholars based in Germany, United States and Denmark. Ulrich Wahn's co-authors include B. Niggemann, Susanne Lau, Christoph Grüber, Renate L. Bergmann, Renate Nickel, Erika von Mutius, Sabina Illi, Michael Kulig, Kirsten Beyer and Thomas Keil and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Nature Immunology.

In The Last Decade

Ulrich Wahn

371 papers receiving 20.1k citations

Hit Papers

Pollen immunotherapy reduces the development of asthma in... 2002 2026 2010 2018 2002 2007 2004 200 400 600

Peers

Ulrich Wahn
Comparison fields: 5 of 166
  • Immunology and Allergy 13.0k
  • Physiology 12.5k
  • Dermatology 6.6k
  • Pulmonary and Respiratory Medicine 4.2k
  • Immunology 1.9k
Replace Bengt Björkstén with:
Bengt Björkstén Sweden
Adnan Ćustović United Kingdom
Marianne van Hage Sweden
Giorgio Ciprandi Italy
Stephen R. Durham United Kingdom
Claus Bachert Belgium
Mimi L.K. Tang Australia
B. Niggemann Germany
Gideon Lack United Kingdom
A. Wesley Burks United States
Bengt Björkstén Sweden View profile →
Citations per field, relative to Ulrich Wahn
Ulrich Wahn · 1×
Citations per year, relative to Ulrich Wahn
Ulrich Wahn · 1×

Countries citing papers authored by Ulrich Wahn

Since Specialization
Citations

This map shows the geographic impact of Ulrich Wahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Wahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Wahn more than expected).

Fields of papers citing papers by Ulrich Wahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Wahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Wahn. The network helps show where Ulrich Wahn may publish in the future.

Co-authorship network of co-authors of Ulrich Wahn

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Wahn. A scholar is included among the top collaborators of Ulrich Wahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Wahn. Ulrich Wahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 2
2 9
3 24
4 1
5 38
6 44
7
MP29-02*provides effective AR symptom control in real life in all patient types regardless of predominant nasal symptom or presence of ocular symptoms: results from Germany
1
8
MP29-02* provides effective AR symptom control in real life in previous or potential treatment failure patients : results from Germany
1
9 73
10 80
11 111
12 107
13 121
14 139
15
Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis (vol 111, pg 763, 2003)
11
16
Guidelines of the DGAI on allergic rhinoconjunctivitis
7
17 27
18 217
19 116
20
[In vitro studies of cellular immunity in chronic bronchitis with and without corticosteroid medication].
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026